Latest Integral membrane proteins Stories
A leading group of Alzheimer's researchers contends that, as biomarkers to detect signals of the disease improve at providing clinically meaningful information, researchers will need guidance on how to constructively disclose test results and track how disclosure impacts both patients and the data collected in research studies.
A ring of protein and pigments, half synthetic and half natural, can be used to quickly prototype light-harvesting antennas that absorb more sunlight than fully natural ones
On the heels of a study which found that copper could factor into the onset and progression of the neurodegenerative condition, a second group of scientists has published research suggesting that iron accumulation could be one of the core contributing factors leading to the onset of Alzheimer's Disease.
In patients with early Alzheimer's disease, disruptions in brain networks emerge about the same time as chemical markers of the disease appear in the spinal fluid.
An element that is essential to all living organisms could also be one of the primary environmental factors that can lead to the onset of Alzheimer’s disease, according to new research appearing in Monday’s edition of the journal Proceedings of the National Academy of Sciences.
Though one might think the brains of people who develop Alzheimer's disease (AD) possess building blocks of the disease absent in healthy brains, for most sufferers, this is not true.
On September 27, 2013, ChanTest will host a User Meeting entitled "Partnerships in Drug Discovery." The meeting will be held at the Westin Boston Waterfront Hotel. Cleveland,
Just 12 molecules of water cause the long post-activation recovery period required by potassium ion channels before they can function again.
UCLA chemists and molecular biologists have for the first time used a "structure-based" approach to drug design to identify compounds with the potential to delay or treat Alzheimer's disease, and possibly Parkinson's, Lou Gehrig's disease and other degenerative disorders.
Researchers at Columbia University Medical Center recently discovered key molecular pathways in the brain that lead to late-onset Alzheimer's disease, the most common form of the disorder.